Circadian Time‐Dependent Differences in Murine Tolerance to the Antihistaminic Agent Loratadine

2005 ◽  
Vol 22 (3) ◽  
pp. 499-514 ◽  
Author(s):  
Dorra Dridi ◽  
Naceur A. Boughattas ◽  
Karim Aouam ◽  
Alain Reinberg ◽  
Mossadok Ben Attia
2009 ◽  
Vol 8 (4) ◽  
pp. 309-316 ◽  
Author(s):  
Xiaoming Yang ◽  
Patricia A. Wood ◽  
Christine Ansell ◽  
William J. M. Hrushesky

2011 ◽  
Vol 32 (3) ◽  
pp. 717-728 ◽  
Author(s):  
K.-H. Lee ◽  
K.-C. Woo ◽  
D.-Y. Kim ◽  
T.-D. Kim ◽  
J. Shin ◽  
...  

2013 ◽  
Vol 44 (3) ◽  
pp. 493-501
Author(s):  
Ichrak Dridi ◽  
Wafa Ben-Cherif ◽  
Karim Aouam ◽  
Mossadok Ben-Attia ◽  
Alain Reinberg ◽  
...  

Science ◽  
2020 ◽  
Vol 371 (6524) ◽  
pp. eabb0738
Author(s):  
Aziz Sancar ◽  
Russell N. Van Gelder

The circadian clock coordinates daily rhythmicity of biochemical, physiologic, and behavioral functions in humans. Gene expression, cell division, and DNA repair are modulated by the clock, which gives rise to the hypothesis that clock dysfunction may predispose individuals to cancer. Although the results of many epidemiologic and animal studies are consistent with there being a role for the clock in the genesis and progression of tumors, available data are insufficient to conclude that clock disruption is generally carcinogenic. Similarly, studies have suggested a circadian time-dependent efficacy of chemotherapy, but clinical trials of chronochemotherapy have not demonstrated improved outcomes compared with conventional regimens. Future hypothesis-driven and discovery-oriented research should focus on specific interactions between clock components and carcinogenic mechanisms to realize the full clinical potential of the relationship between clocks and cancer.


1993 ◽  
Vol 10 (2) ◽  
pp. 81-86
Author(s):  
D. Zeruesenay ◽  
W. Siegmund ◽  
G. Franke ◽  
M. Zschiesche

Sign in / Sign up

Export Citation Format

Share Document